Dou et al. demonstrated that the imbalance of TREM1 and TREM2 in the liver was involved in the pathological process of NASH, with a close association between the severity of fatty liver and the rise of TREM1 and reduction of TREM2 [29]. The gene discussed is TREM2; the disease is metabolic dysfunction-associated steatohepatitis.